News release 2015
Survey results released by the European Centre for Disease Prevention and Control (ECDC) show that the situation continues to worsen with regard to the spread of carbapenemase-producing Enterobacteriaceae (CPE) in the EU, with 8 countries reporting an interregional spread and 3 countries an endemic situation. This means that in these 3 countries most hospitals are repeatedly seeing patients that cannot be treated with carbapenems, a last-line antibiotic group.
On the occasion of the 8th European Antibiotic Awareness Day, ECDC is releasing the results of the European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) on the spread in Europe’s hospitals of bacteria resistant to carbapenems. On the other hand, the survey also shows that national capacity for the containment of CPE in the EU is increasing. ECDC is also releasing its latest data on antibiotic resistance (EARS-Net) and consumption (ESAC-Net) in Europe.
Partners & Resources
The European Centre for Disease Prevention and Control (ECDC) works closely with the European Commission and with other EU agencies, stakeholders and organisations running awareness campaigns on prudent use of antibiotics - in line with the European Commission ‘One health’ integrated approach.Read more
Antimicrobial resistance surveillance in Europe 2014
This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci.Read more